SHANGHAI, Feb 5 (Reuters) - Japan's Eisai will licence Shanghai Henlius Biotech's lung cancer drug Hansizhuang, paying $75 million upfront and up to $313.34 million more if milestones are met, the ... ( read original story ...)
Shanghai airport lays on Spring Festival welcome for world travelers
Shanghai Pudong International Airport added a vibrant dash of traditional festivity to its bustling terminals on Thursday, as its two one-stop international service stations played host to Spring ... ( read original story ...)
Shanghai NPC Deputies Call for Improving Transformation of Sci-Tech Achievements
Improving and facilitating the transformation of scientific and technological achievements, as well as creating a favorable policy, research and development, and industrial ecosystem in support, was ... ( read original story ...)
Chinese robotics firms flock to Hong Kong IPOs for lower barriers
On the 6th of last month at the ‘CES 2026’ event, the world’s largest home appliance and IT exhibition held in Las Vegas, Nevada, a humanoid robot named ‘A2’ from Chinese robotics company AgiBot, ... ( read original story ...)
LandSpace Pushes Ahead With $1.1 Billion IPO as Exchange Reviews Application
LandSpace’s application was accepted by the Shanghai bourse on Dec. 31. The company is seeking to raise 7.5 billion yuan ($1.1 billion) to scale up production of reusable rockets and fund further ... ( read original story ...)
Rethinking Shakespeare in Shanghai
A recent production of “Othello” proves that small creative flowers can grow between the dreary slabs of cultural concrete laid by the Communist Party. ( read original story ...)
Bian Ximing made $3 billion from long gold bets on the Shanghai Futures Exchange.
Bian Ximing made nearly $3 billion trading gold. Then he flipped the script and made another $500 million when silver crashed. This was a cold, calculated betting in a market spinning out of control. ( read original story ...)